DAPAGLIFLOZIN

ਉਤਪਾਦ ਝਲਕ

About DAPAGLIFLOZIN

DAPAGLIFLOZIN is a prescription medication used to treat type 2 diabetes. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove excess glucose from the blood and excrete it in the urine.

Key Benefits & Uses

• Improves blood sugar control and reduces HbA1c levels in patients with type 2 diabetes.
• Helps to reduce the risk of major adverse cardiovascular events, such as heart attack, stroke, and death, in patients with established cardiovascular disease.
• May also help to reduce blood pressure and body weight in patients with type 2 diabetes.

Active Ingredient & Action

DAPAGLIFLOZIN is the active ingredient in this medication. It works by inhibiting the SGLT2 protein in the kidneys, which helps to reduce glucose reabsorption and increase glucose excretion in the urine. This leads to a decrease in blood glucose levels and an improvement in glycemic control.

Important Notes

Before taking DAPAGLIFLOZIN, it is essential to inform your doctor if you have any underlying medical conditions, such as kidney disease, liver disease, or heart failure. You should also inform your doctor about any medications you are currently taking, including blood thinners and diuretics. DAPAGLIFLOZIN may increase the risk of dehydration, especially in patients with underlying kidney disease. It is crucial to drink plenty of water and monitor your urine output while taking this medication.